The effects of extraction with isooctane (540841) on substrate hemoprotein spectrophotometric binding properties of liver microsomes were studied in-vitro. Liver microsomes obtained from male Holtzman-rats, pretreated with 50mg/kg sodium-phenobarbital daily for 3 days were used. Twenty milliliters (ml) microsomal suspension were extracted with 13.4ml isooctane or unextracted and assayed for protein, cytochrome-b5, cytochrome-P450, and the extent of aniline/microsomal binding. The effect on the hexobarbital binding spectrum of the preparations was investigated. The effects on aminopyrine-demethylase and acetanilide-hydroxylase activity were evaluated. The extracts were examined by thin layer chromatography (TLC). Extraction with isooctane reduced microsomal protein content by about 80 percent. Microsomal cytochrome-b5 and cytochrome-P450 concentrations were reduced to a similar extent, about 80 percent, so that the relative proportions per milligram protein were not significantly altered. The apparent aniline/microsomal dissociation constants were not significantly affected. The type-I difference spectrum seen with hexobarbital, peak at 390 nanometers (nm) and trough at 425nm, disappeared at concentrations of 0.8 or 4.9 millimolar (mM). At hexobarbital concentrations of 12.5mM or higher a type-II binding spectrum was obtained. Isooctane did not inhibit aminopyrine-demethylase or acetanilide-hydroxylase activity. TLC spots corresponding to phosphatidylcholine and phosphatidylethanolamine were found in the isooctane extracts. The authors conclude that after isooctane extraction rat liver microsomes cannot bind hexobarbital and produce a type-I difference spectrum. Isooctane apparently destroys or modifies the normal hexobarbital binding form of cytochrome-P450 in liver microsomes.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.